We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » CDC Set to Meet A Second Time After Delaying Vote on J&J Blood Clot Concerns
CDC Set to Meet A Second Time After Delaying Vote on J&J Blood Clot Concerns
The Centers for Disease Control and Prevention (CDC) will convene a second emergency meeting of its Advisory Committee on Immunization Practices at the end of the week to discuss the use of Johnson & Johnson (J&J)’s COVID-19 vaccine, following a delayed vote at its initial discussion on cases of very rare blood clots seen in vaccinated patients.